Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence

NCT00630201 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Dependence

Interventions

DRUG: Probuphine (buprenorphine implant)

Sponsor

Titan Pharmaceuticals